Literature DB >> 239050

Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria.

J B Robbins, R Schneerson, M P Glode, W Vann, M S Schiffer, T Y Liu, J C Parke, C Huntley.   

Abstract

Antigenic structures may be shared among naturally occurring polymers, including proteins and polysaccharides. Proteins are polymers of amino acids. Cross-reactions between proteins are due to similarities in their overall shape rather than their individual amino acid components. Cross-reactions have been demonstrated among proteins with similar evolutionary development and structure, such as serum albumins or immunoglobulins. Polysaccharides are polymers of monosaccharides. In contrast to proteins, antigenic specificities may be conferred by mono-, di-, and trisaccharides. Since there are about 150 known naturally occurring monosaccharides, it is not unexpected that cross-reactions are demonstrable between polysaccharides from widely divergent sources.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 239050     DOI： 10.1016/0091-6749(75)90119-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


  15 in total

1.  Cross-reactions of lipopolysaccharides of Pseudomonas aeruginosa in antipneumococcal and other antisera.

Authors:  M Heidelberger; D Horton; T H Haskell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. The Collaborative Vaccine Study Group.

Authors:  D M Granoff; P G Shackelford; S J Holmes; A H Lucas
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 3.  Content and dynamics of the human antibody variable region repertoire to the Haemophilus influenzae type b polysaccharide.

Authors:  D C Reason; A H Lucas
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?

Authors:  A Soininen; G van den Dobbelsteen; L Oomen; H Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

5.  Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.

Authors:  P T Heath; J Bowen-Morris; D Griffiths; H Griffiths; D W Crook; E R Moxon
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

6.  Antifungal activity of a human antiglucuronoxylomannan antibody.

Authors:  Z Zhong; L A Pirofski
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 7.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

8.  Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci.

Authors:  N D Russell; J R Corvalan; M L Gallo; C G Davis; L a Pirofski
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 9.  Pneumococcal Capsules and Their Types: Past, Present, and Future.

Authors:  K Aaron Geno; Gwendolyn L Gilbert; Joon Young Song; Ian C Skovsted; Keith P Klugman; Christopher Jones; Helle B Konradsen; Moon H Nahm
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

10.  Clinically significant cross-reactions with counterimmunoelectrophoresis between pneumococcus type 6 and Haemophilus influenzae type b.

Authors:  T L Ballard; A Spangler; M H Roe; M P Glode
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.